CORMEDIX INC WTS EXP 04/30/15
CRMD.WS
CRMD.WS was delisted on the 29th of April, 2015.
3 hedge funds and large institutions have $72K invested in CORMEDIX INC WTS EXP 04/30/15 in 2014 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
350% more capital invested
Capital invested by funds: $16K → $72K (+$56K)
25% less funds holding
Funds holding: 4 → 3 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
-$3.06K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
AQR Capital Management
Greenwich,
Connecticut
| $64K | – | – | – |
|
|
EM
2
Elliott Management
New York
| $7K | – | – | – |
|
|
U
3
UBS
Zurich,
Switzerland
| $1K | -$3.06K | -5,700 | -77% |
|
CRMD.WS Hedge Fund Activity: Q1 2014 in Review
3 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in CORMEDIX INC WTS EXP 04/30/15 (CRMD.WS) for Q1 2014, worth a combined $72K — up 350% from $16K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CRMD.WS and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was UBS, cutting an estimated $3.06K.
- 3 institutional investors held CORMEDIX INC WTS EXP 04/30/15 (CRMD.WS) as of Q1 2014, down from 4 in Q4 2013.
- Funds reported $72K of CORMEDIX INC WTS EXP 04/30/15 stock for Q1 2014, up 350% quarter-over-quarter.
- 0 funds opened new CORMEDIX INC WTS EXP 04/30/15 positions in Q1 2014 and 1 closed out, a net change of -1 holder.
- The largest CORMEDIX INC WTS EXP 04/30/15 seller in Q1 2014 was UBS, an estimated $3.06K sold.
Based on aggregated 13F filings for Q1 2014.